openPR Logo
Press release

Osteoarthritis-Pipeline Review H2 2017

01-11-2018 04:14 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: ReportsWeb

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis-Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape.

Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery, medications like non-steroidal anti-inflammatory drugs (NSAIDs) and exercise.

Get Sample Copy of Report@ http://www.reportsweb.com/inquiry&RW00011022660/sample

Company Profiles:
4P-Pharma SAS
AbbVie Inc
Abiogen Pharma SpA
Ablynx NV
Amgen Inc
Amura Holdings Ltd
Anterogen Co Ltd
Asahi Kasei Pharma Corp
Axsome Therapeutics Inc
Biopharm GmbH
Bone Therapeutics SA
Can-Fite BioPharma Ltd
Cardax Inc
Cellular Biomedicine Group Inc
Corestem Inc
Dong-A Socio Holdings Co Ltd
Eli Lilly and Company
Evgen Pharma Plc
Galapagos NV
Gemphire Therapeutics Inc
Genequine Biotherapeutics GmbH
GlaxoSmithKline Plc
InKemia IUCT Group SA
International Stem Cell Corp
Jeil Pharmaceutical Co Ltd
K-Stemcell Co Ltd
Kang Stem Biotech Co Ltd
Lateral Pharma Pty Ltd
Levolta Pharmaceuticals Inc
LG Chem, Ltd.
Marina Biotech Inc
Medivir AB
Merck KGaA
Mesoblast Ltd

Read More Information and Full TOC of the Report@ http://www.reportsweb.com/osteoarthritis-pipeline-review-h2-2017

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Osteoarthritis-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Osteoarthritis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 8, 16, 9, 44 and 11 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 7 and 5 molecules, respectively.

Buy This Report@ http://www.reportsweb.com/buy&RW00011022660/buy/2000

Osteoarthritis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

-The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoarthritis (Musculoskeletal Disorders).
-The pipeline guide reviews pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
-The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
-The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

Inquiry for This Report@ http://www.reportsweb.com/inquiry&RW00011022660/buying

-The pipeline guide reviews key companies involved in Osteoarthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
-The pipeline guide evaluates Osteoarthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
-The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
-The pipeline guide reviews latest news related to pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders)

About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoarthritis-Pipeline Review H2 2017 here

News-ID: 896624 • Views: 290

More Releases from ReportsWeb

Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles Summary "Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy. The report provides in depth analysis on global renewable power market and
Aircraft Ignition System Market Growth Opportunity and Future Forecast by Leadin …
ReportsWeb.com has announced the addition of the “Global Aircraft Ignition System Market Insights Forecast to 2025” The report classifies the global Aircraft Ignition System Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. An ignition system generates a spark or heats an electrode to a high temperature to ignite a fuel-air mixture in spark ignition internal combustion engines oil-fired

All 5 Releases


More Releases for Osteoarthritis

Osteoarthritis Treatment Market by Product (Drugs, Hyaluronic acid Injection) by …
Global Osteoarthritis Treatment Market was valued at USD XX Billion in the year 2017. Global Osteoarthritis Treatment Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE369 North America region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At a
Osteoarthritis Global Clinical Trials Review, H1, 2016
ReportsWeb.com published “Osteoarthritis” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. GET Sample Copy at http://www.reportsweb.com/inquiry&RW0001178647/sample Reason to Buy Original Content: - The UK and the EU will be at the forefront of moves to practically apply the principles of open banking in 2017, spurred on by regulatory demands. The
Osteoarthritis - Pipeline Review, H2 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older
Osteoarthritis - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2017, provides an overview of the Osteoarthritis (Immunology) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries
Osteoarthritis Pharmaceutical and Healthcare Pipeline Review H2
Pune, India, 28th August 2017: WiseGuyReports announced addition of new report, titled “Osteoarthritis - Pipeline Review, H2 2017”. Summary Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery,
Osteoarthritis - Pipeline Review, H1 2017
ReportsWeb.com has announced the addition of the “Osteoarthritis - Pipeline Review, H1 2017” this report provides an overview of the Osteoarthritis (Immunology) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint